Vioxx

Vioxx is a nonsteroidal anti-inflammatory drug (NSAID) that was developed by Merck & Co. and approved by the United States Food and Drug Administration (FDA) in 1999 for the treatment of osteoarthritis, rheumatoid arthritis, and acute pain management. The drug was also used to treat menstrual cramps and migraines, and was often prescribed by physicians such as Dr. Eric Topol and Dr. Steven Nissen. Merck & Co. invested heavily in the marketing of the drug, with celebrity endorsements from Dorothy Hamill and Bruce Jenner.

Introduction

Vioxx was a widely prescribed medication that was used to treat a variety of conditions, including osteoarthritis, rheumatoid arthritis, and acute pain management. The drug was developed by Merck & Co. and was approved by the United States Food and Drug Administration (FDA) in 1999. Dr. Alastair Wood, a pharmacologist at Vanderbilt University, was involved in the early development of the drug, and Dr. Garret FitzGerald, a professor at the University of Pennsylvania, conducted research on the drug's mechanism of action. The drug was also studied by researchers at Stanford University, Harvard University, and the National Institutes of Health (NIH).

History

The development of Vioxx began in the 1990s, when Merck & Co. was searching for a new NSAID that would be safer and more effective than existing medications. The company partnered with Searle, a pharmaceutical company that was later acquired by Pfizer, to develop the drug. Dr. Edward Scolnick, a researcher at Merck & Co., played a key role in the development of the drug, and Dr. Raymond Gilmartin, the CEO of Merck & Co., oversaw the company's efforts to bring the drug to market. The drug was approved by the FDA in 1999, and was launched in the United States with a large marketing campaign that included advertising in medical journals such as the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM).

Mechanism_of_action

Vioxx works by inhibiting the production of prostaglandins, which are hormones that cause inflammation and pain. The drug specifically targets the COX-2 enzyme, which is involved in the production of prostaglandins. This mechanism of action is similar to that of other NSAIDs, such as ibuprofen and naproxen, which are available over-the-counter at pharmacies such as CVS Pharmacy and Walgreens. However, Vioxx was designed to be more selective in its inhibition of the COX-2 enzyme, which was thought to reduce the risk of gastrointestinal side effects such as ulcers and bleeding. Researchers at Duke University and the University of California, San Francisco (UCSF) have studied the mechanism of action of Vioxx and its effects on the body.

Controversy_and_withdrawal

In 2004, Vioxx was withdrawn from the market due to concerns about its safety. A study published in the New England Journal of Medicine (NEJM) found that the drug increased the risk of heart attacks and strokes in patients who took it for more than 18 months. The study was conducted by researchers at Cleveland Clinic and the University of Texas Southwestern Medical Center, and was funded by Merck & Co.. The FDA issued a warning about the drug's safety, and Merck & Co. voluntarily withdrew it from the market. The withdrawal of Vioxx was widely covered in the media, with news articles in The New York Times, The Wall Street Journal, and USA Today. Lawyers such as Mark Lanier and Richard Scruggs filed lawsuits on behalf of patients who had taken the drug, and courts such as the United States District Court for the Eastern District of Louisiana heard cases related to the drug's safety.

Side_effects

The side effects of Vioxx were similar to those of other NSAIDs, and included nausea, dizziness, and headaches. However, the drug was also associated with an increased risk of cardiovascular events such as heart attacks and strokes. Researchers at Johns Hopkins University and the University of Michigan have studied the side effects of Vioxx and their impact on patients. The FDA has also issued warnings about the safety of other NSAIDs, including Celebrex, which is manufactured by Pfizer, and Bextra, which was withdrawn from the market in 2005. Physicians such as Dr. Sanjay Gupta and Dr. Nancy Snyderman have discussed the side effects of Vioxx and other NSAIDs on television programs such as CNN and NBC News. Hospitals such as Massachusetts General Hospital and University of California, Los Angeles (UCLA) have also treated patients who experienced side effects from the drug. Category:Pharmaceuticals